Download PDFPDF

Case–control and prospective studies of dietary α-linolenic acid intake and prostate cancer risk: a meta-analysis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Dietary alpha-linolenic acid intake and prostate cancer risk: A dose-response analysis of observational studies
    • Long Zhai, Postgraduate
    • Other Contributors:
      • Dongfeng Zhang and Yaoming Zhai

    Abstract Alpha-linolenic acid (ALA) consumption has been linked to risk of prostate cancer theoretically, but the findings were conflicting from observational studies. Results from recent meta-analysis suggested a small risk, moderate protective and no effect of alpha-linolenic acid consumption on prostate cancer risk. However, the relationship, if exists, between alpha-linolenic acid consumption and prostate cancer ris...

    Show More
    Conflict of Interest:
    None declared.